These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 34619099)

  • 21. How to organise travel restrictions in the new future: lessons from the COVID-19 response in Hong Kong and Singapore.
    Lai D; Cai Y; Chan TH; Gan D; Hurson AN; Zhang YD
    BMJ Glob Health; 2022 Feb; 7(2):. PubMed ID: 35228258
    [TBL] [Abstract][Full Text] [Related]  

  • 22. COVID-19 in Hong Kong - Public health, food safety, and animal vectors perspectives.
    Hon KL; Leung KKY; Tang JW; Leung AKC; Li Y
    J Virol Methods; 2021 Apr; 290():114036. PubMed ID: 33285191
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Charting elimination in the pandemic: a SARS-CoV-2 serosurvey of blood donors in New Zealand.
    Carlton LH; Chen T; Whitcombe AL; McGregor R; Scheurich G; Sheen CR; Dickson JM; Bullen C; Chiang A; Exeter DJ; Paynter J; Baker MG; Charlewood R; Moreland NJ
    Epidemiol Infect; 2021 Jul; 149():e173. PubMed ID: 34668464
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New Zealand's science-led response to the SARS-CoV-2 pandemic.
    Geoghegan JL; Moreland NJ; Le Gros G; Ussher JE
    Nat Immunol; 2021 Mar; 22(3):262-263. PubMed ID: 33627881
    [No Abstract]   [Full Text] [Related]  

  • 25. COVID-19, 20, 21: lessons from New Zealand's 2020 response for 2021 and beyond.
    Bloomfield A
    N Z Med J; 2021 Feb; 134(1529):7-9. PubMed ID: 33582703
    [No Abstract]   [Full Text] [Related]  

  • 26. Epidemiological profiles of SARS-CoV and SARS-Cov-2 in Singapore and its promising containment strategies.
    Chaturvedi R; Malhotra S; Sharma A
    J Glob Health; 2021 Jan; 11():03027. PubMed ID: 33692882
    [No Abstract]   [Full Text] [Related]  

  • 27. Policy disparities in fighting COVID-19 among Japan, Italy, Singapore and China.
    Wang X; Shi L; Zhang Y; Chen H; Sun G
    Int J Equity Health; 2021 Jan; 20(1):33. PubMed ID: 33441144
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Behavioural insights and attitudes on community masking during the initial spread of COVID-19 in Hong Kong.
    Tam VCW; Tam SY; Khaw ML; Law HKW; Chan CPL; Lee SWY
    Hong Kong Med J; 2021 Apr; 27(2):106-112. PubMed ID: 33762440
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Seroprevalence of Unidentified SARS-CoV-2 Infection in Hong Kong During 3 Pandemic Waves.
    Boon SS; Wong MCS; Ng RWY; Leung DTM; Chen Z; Lai CKC; Ho WCS; Huang J; Wong BKC; Fung KSC; Chan PKS
    JAMA Netw Open; 2021 Nov; 4(11):e2132923. PubMed ID: 34779848
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chasing elimination through lockdowns is stamping out livelihoods and lives [includes Addendum].
    Sundborn G; Thornley S; Jackson M; Morris G; Blackham M; Schofield G; Doehring R; Goedeke R; Chaudhuri A
    J Prim Health Care; 2020 Dec; 12(4):298-301. PubMed ID: 33349316
    [No Abstract]   [Full Text] [Related]  

  • 31. Understanding the impact of rapid antigen tests on SARS-CoV-2 transmission in the fifth wave of COVID-19 in Hong Kong in early 2022.
    Du Z; Tian L; Jin DY
    Emerg Microbes Infect; 2022 Dec; 11(1):1394-1401. PubMed ID: 35536564
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Age, source, and future risk of COVID-19 infections in two settings of Hong Kong and Singapore.
    Zhu S; Tao J; Gao H; He D
    BMC Res Notes; 2020 Jul; 13(1):336. PubMed ID: 32660556
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Psychological and behavioral responses to the declaration of COVID-19 as a pandemic: A comparative study of Hong Kong, Singapore, and the U.S.
    Liu JJ; Mukhopadhyay A; Yeung CW
    PLoS One; 2022; 17(10):e0275854. PubMed ID: 36215259
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inferring super-spreading from transmission clusters of COVID-19 in Hong Kong, Japan, and Singapore.
    Kwok KO; Chan HHH; Huang Y; Hui DSC; Tambyah PA; Wei WI; Chau PYK; Wong SYS; Tang JWT
    J Hosp Infect; 2020 Aug; 105(4):682-685. PubMed ID: 32446721
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A novel comprehensive metric to assess effectiveness of COVID-19 testing: Inter-country comparison and association with geography, government, and policy response.
    Kuster AC; Overgaard HJ
    PLoS One; 2021; 16(3):e0248176. PubMed ID: 33667280
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Guest Editorial: New Zealand research and international perspectives on the pandemic.
    Romain A
    J Prim Health Care; 2020 Sep; 12(3):191-192. PubMed ID: 32988438
    [No Abstract]   [Full Text] [Related]  

  • 37. Effects of School-Based Preventive Measures on COVID-19 Incidence, Hong Kong, 2022.
    Tsang TK; Huang X; Fong MW; Wang C; Lau EHY; Wu P; Cowling BJ
    Emerg Infect Dis; 2023 Sep; 29(9):1850-1854. PubMed ID: 37490926
    [TBL] [Abstract][Full Text] [Related]  

  • 38. COVID-19 from Wellington New Zealand.
    Gray B
    J Bioeth Inq; 2020 Dec; 17(4):633-638. PubMed ID: 33169244
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The next phase in Aotearoa New Zealand's COVID-19 response: a tight suppression strategy may be the best option.
    Baker MG; Kvalsvig A; Crengle S; Harwood M; Tukuitonga C; Betty B; Bonning J; Wilson N
    N Z Med J; 2021 Nov; 134(1546):8-16. PubMed ID: 34855729
    [No Abstract]   [Full Text] [Related]  

  • 40. Decreased Influenza Incidence under COVID-19 Control Measures, Singapore.
    Soo RJJ; Chiew CJ; Ma S; Pung R; Lee V
    Emerg Infect Dis; 2020 Aug; 26(8):1933-1935. PubMed ID: 32339092
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.